(Q52858483)

9 May 2018

title

Is plasma N-BNP a good indicator of the functional reserve of failing hearts? The FRESH-BNP study. (English)

1 reference

9 May 2018

2

Leong L Ng

1 reference

9 May 2018

author name string

Simon G Williams

1

1 reference

9 May 2018

Russell J O'Brien

3

1 reference

9 May 2018

Steve Taylor

4

1 reference

9 May 2018

D Jay Wright

5

1 reference

9 May 2018

Lip-Bun Tan

6

1 reference

9 May 2018

publication date

1 December 2004

1 reference

9 May 2018

European Journal of Heart Failure

published in

1 reference

9 May 2018

volume

6

1 reference

9 May 2018

issue

7

1 reference

9 May 2018

page(s)

891-900

1 reference

9 May 2018

Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

BNP and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

B-type natriuretic peptide in the diagnosis and management of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

Plasma natriuretic peptide levels and the risk of cardiovascular events and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

B-type natriuretic peptide predicts sudden death in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

Biochemical detection of left-ventricular systolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

Responses of atrial natriuretic peptide and brain natriuretic peptide to exercise in patients with chronic heart failure and normal control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

Relationship between natriuretic peptides and hemodynamics in patients with heart failure at rest and after ergometric exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

Clinical significance of brain natriuretic peptide in patients with postmyocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

Bedside B-type natriuretic peptide and functional capacity in chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

Peak exercise cardiac power output; a direct indicator of cardiac function strongly predictive of prognosis in chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

Role of cardiac power in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

Plasma urotensin in human systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

Rapid bedside measurement of brain natriuretic peptide in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

Clinical and research implications of new concepts in the assessment of cardiac pumping performance in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

Prognostic information provided by serial measurements of brain natriuretic peptide in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

Guidelines for the diagnosis and treatment of chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Gu

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.005

10.1016/J.EJHEART.2004.03.005

21 January 2018

Identifiers

DOI

1 reference

9 May 2018

1 reference

9 May 2018